Replies to post #84915 on Amarantus Bioscience Holdings Inc (AMBS)

[Riskreturn168]

Where will Amarantus come up with the money to conduct a phase 2 trial on a Parkinson's drug? We haven't heard much about this lately.

[Skeetz99]

Great post!!! A Phase 2b ready compound will add additional value to our Market cap. I am guessing the wait is due to funding requirements....but once things move forward..it could add a nice incremental increase in value.

Its hard to believe that our PPS sits at less than $31mm. More importantly, the cash situation has been greatly improved and the Balance sheet looks solid.

Finally, I am awaiting the "game changer" announcement which will get us closer to a more reasonable valuation:

Top possibilities for the "Game changer" announcement:
1) LymPro validation data with Becton Dickinson (maybe a partnership as well).
2) A new Seeking Alpha investment report (due soon); an huge upward re evaluation of the projected value (could help increase the PPS this time around...much further advanced in their Drug and Diagnostic programs).
3) MANF Orphan data for Diabetes (and perhaps a possibility for a partnership with a Pharma.).
4) The new Orphan data for Retinitis Pigmentosa could be a blockbuster (its a $10 billion dollar market). I think this will be a highly successful program (and will lead to a Partnership sooner than the other programs...just because Gerald announced it was there new lead program at the Rodman and Renshaw conference).
5) A surprise factor...who knows what could be announced at anytime ..its what I really like about this company.

Exciting times ahead!!! GLTA!!!

[DOLPHY]

What is the L-Dopa *** thing you are talking about.We are not all medical people and some of the subjects mentioned here assumes that we all do know about these things. Unfortunately for me your post means nothing.